Product Details
Cefepime Injection powder for solution
500mg/1g/2g
Product Description :
CEFEPIME INJECTION 500 mg / 1 g / 2 g
Sterile Powder for Solution for Intravenous or Intramuscular Administration
1. COMPOSITION
Each vial contains:
• Cefepime Hydrochloride equivalent to Cefepime 500 mg / 1 g / 2 g.
• Excipients: As applicable.
2. PHARMACEUTICAL FORM
Sterile, white to off-white powder for solution for intravenous or intramuscular administration.
3. THERAPEUTIC CLASS
Fourth-Generation Cephalosporin Antibiotic.
4. INDICATIONS
Cefepime Injection is indicated for the treatment of susceptible bacterial infections, including:
• Lower respiratory tract infections.
• Urinary tract infections.
• Skin and soft-tissue infections.
• Intra-abdominal infections.
• Biliary tract infections.
• Bone and joint infections.
• Febrile neutropenia with suspected bacterial infection.
• Septicemia and other serious bacterial infections.
Treatment should be guided by the susceptibility of the causative organism and applicable antimicrobial guidelines.
5. CONTRAINDICATIONS
• Hypersensitivity to cefepime, cephalosporins, or any component of the formulation.
• History of severe immediate hypersensitivity reactions to beta-lactam antibiotics.
6. DRUG INTERACTIONS
• Concomitant nephrotoxic medicines may increase the risk of renal toxicity.
• Aminoglycosides may increase the risk of nephrotoxicity.
• Loop diuretics may require caution when used with cefepime.
• Other medicines affecting renal function should be used with caution.
The treating physician should review all concomitant medications before administration.
7. ADMINISTRATION
For intravenous or intramuscular administration after reconstitution with a compatible diluent under aseptic conditions. Administer according to the approved product information and institutional protocol. Dose adjustment may be required in patients with renal impairment.
8. STORAGE
Store according to the storage conditions stated on the approved product label.
